KHI Board of Directors and Federal Liaisons
Chair
- Uptal D. Patel, MD (2025)
FDA Point of Contact
- Kristen Miller, PharmD (2025)
Members
- Shuchi Anand, MD, MS (2027)
- Mary Baliker (2025)
- Steven K. Burke, MD (2027)
- Jorge Cerda, MD, MS, FASN (2025)
- Bruce F. Culleton, MD (2025)
- Manisha Dadhania, MBA (2025)
- Ogo I. Egbuna, MD, MSc, FASN (2027)
- Jay Elliott, PhD (2025)
- Vanessa A. Evans, MA (2025)
- Kevin John Fowler (2025)
- Amanda Grandinetti, MPH (2025)
- Nicolas Jose Guzman, MD (2025)
- Meg Jardine, MBBS, PhD (2025)
- Lauren L. Lee, MA (2027)
- John Mcdermott, MBA (2025)
- Vandana Dua Niyyar, MD, FASN (2026)
- Ikenna Okezie, MD, MBA (2025)
- Robert M. Perkins, MD, MPH (2027)
- Glenda V. Roberts (2025)
- Bruce M. Robinson, MD, MS, FASN (2025)
- Alain Romero, PharmD, PhD (2025)
- Brigitte Schiller, MD, FASN (2025)
- David Soergel, MD (2025)
- Michael Spigler (2025)
- Howard Trachtman, MD, MLA, FASN (2026)
- Amy Young (2025)
FDA Liaisons
- Kellie Kelm, PhD (2025)
- Aliza M. Thompson, MD, MS (2025)
Council Liaison
- Linda F. Fried, MD, MPH, FASN (2025)
Ex-Officio
- Curtis Warfield, MS (2026)
Disclosures as of September 2021 can be found here.